News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
AMI Rebuts False Information Flouted by Today Tonight
June 14, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SYDNEY, Australia--(BUSINESS WIRE)--AMI (OTCBB:AVMD), a leading provider of treatments for erectile dysfunction and premature ejaculation in Australia, issues the following statement in response to allegations made by Today Tonight:
Twitter
LinkedIn
Facebook
Email
Print
Australia
MORE ON THIS TOPIC
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
March 7, 2025
·
2 min read
·
Tristan Manalac
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Drug Development
Kazia’s Star Asset Suffers Surprise Letdown in Global Glioblastoma Study
August 2, 2022
·
3 min read
·
Tristan Manalac
Drug Development
Sapience, Intensity, Kazia and Transcenta Tout Early Success at ASCO
June 3, 2022
·
3 min read
·
Vanessa Doctor, RN
